Prevalence and gender distribution of the metabolic syndrome
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Metabolic syndrome (MetS) is a cardiovascular risk factor of public health significance and of recent has become a topical issue. The prevalence of diabetes mellitus (DM) is on the increase and with this scenario, a possible increase in burden of DM which may be largely attributed to cardiovascular complications is expected. The objective of this report is to determine the prevalence of the MetS and compare gender characteristics in subjects with type 2 DM. METHODS: Subjects with type 2 DM were recruited from an urban hospital for the study. Clinical data was obtained by interviewing the patients and referring to their case folders. The anthropometric indices and blood pressure measurements were documented. Laboratory parameters analysed for included total cholesterol, high density and low density cholesterol, triglyceride and glycosylated haemoglobin. Statistical analysis included usage of Student's t test and chi square. RESULTS: 963 patients with type 2 DM aged between 35-85 years were recruited for the study. The main outcome measures included the prevalence of the metabolic syndrome and the gender differences of its components. The prevalence of the metabolic syndrome was 86%. The frequency of occurrence of the MetS was similar for men (83%) and women (86%) and increased with age in both sexes. The prevalence of MetS increased from 11% among participants aged 20 through 29 years to 89% in participants aged 70 through 79. In our patients with DM, the commonest occurring and least detected MetS defining parameters are central obesity and elevated triglyceride levels respectively. The components of the MetS that differed significantly in both sexes was HDL-C. The combination of the components of the MetS were comparable in both genders and 5.8% of the subjects with the MetS had all components of the MetS. CONCLUSION: The prevalence of the MetS in type 2DM is high in both genders and increases with age thus posing a potential high cardiovascular risk in this group of patients. The modifiable risk factors for the MetS should be a focus point in the management of subjects with type 2 DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“The prevalence of metabolic syndrome increases with increasing glucose intolerance [5] and with the increasing world wide prevalence of DM, the expected increase in the frequency of occurrence of the MetS will expectedly be in geometric proportions.”
Background
Cited by
Smith, J. J., Eather, N., Morgan, P. J., Plotnikoff, R. C., Faigenbaum, A. D., & Lubans, D. R. (2014) · Sports Medicine · doi:10.1007/s40279-014-0196-4 · Cited by 795
Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
Buitrago-Lopez, A., Sanderson, J., Johnson, L., Warnakula, S., Wood, A., Di Angelantonio, E., & Franco, O. H. (2011) · BMJ · doi:10.1136/bmj.d4488 · Cited by 252
“Furthermore, about a fifth of the world’s adult population are thought to have metabolic syndrome, a cluster of factors associated with an increased risk of type 2 diabetes and cardiovascular disease.”
BackgroundAdeloye, D., Ige, J. O., Aderemi, A. V., Adeleye, N., Amoo, E. O., Auta, A., & Oni, G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015424 · Cited by 169
The metabolic syndrome in Africa: Current trends
Okafor, C. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91191 · Cited by 168
“Indian Journal of Endocrinology and Metabolism / Jan-Feb 2012 / Vol 16 | Issue 1 60 metabolic syndrome, LDL-C was found to be the most common lipid abnormality followed by reduced HDL-C which occurred in about 60% of the subjects as reported by Ogbera.[29] There is a great need for dyslipidemia to be addressed because…”
BackgroundResultInfluentialSuliburska, J., Bogdanski, P., Szulinska, M., Pupek-Musialik, D., & Jablecka, A. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0533-7 · Cited by 47
Metadata
- Authors
- Ogbera, A. O.
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2010-01-12
- Volume
- 2
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1758-5996 (ISSN-L)
- OpenAlex
- W2134354703
- Cited by
- 204
- References
- 2
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and gender distribution of the metabolic syndrome. https://app.cochat.ai/papers/10.1186/1758-5996-2-1
- The paper
- Ogbera, A. O. (2010). Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/1758-5996-2-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.